Advertisement: EBCam mid banner
Advertisement: Mogrify
Advertisement: Cambridge Network
Advertisement: China mid banner
ARM Innovation Hub
Advertisement: Simpsons Creative
RealVNC mid banner careers
Advertisement: RSM
Advertisement EY mid banner
Advertisement: Innova Systems
Barr Ellison Solicitors – commercial property
Mid banner advertisement: BDO
RealVNC mid-banner general
7 April, 2020 - 16:51 By Kate Sweeney

Cambridge companies collaborate to beat coronavirus

Cambridge big pharma and academia have joined forces in the battle against coronavirus wth the launch of a dedicated laboratory in the city.

AstraZeneca, GSK and Cambridge University have set up a new COVID-19 testing laboratory at the University’s Anne McLaren laboratory. The facility will be used for high throughput screening for COVID-19 testing and to explore the use of alternative chemical reagents for test kits in order to help overcome current supply shortages. 

Alongside this new testing facility, AstraZeneca and GSK are working together to provide process optimisation support to the UK national testing centres in Milton Keynes, Alderley Park and Glasgow for COVID-19, providing expertise in automation and robotics to help the national testing system to continue to expand capacity over the coming weeks.

While diagnostic testing is not part of either company’s core business, both AstraZeneca and GSK are moving swiftly to help where possible - with a focus on providing their world class scientific and technical expertise - working both with the Government’s screening programme and alongside the wider life sciences sector and specialist diagnostic companies.

Newsletter Subscription

Stay informed of the latest news and features